Background: Microvascular blood flow in the human skin is subject to rhythmic variations reflecting the influence of heartbeat, respiration, intrinsic myogenic activity, neurogenic factors and endothelial activity. The aim of our study was to test the hypothesis that basal skin blood flow (BSBF) and its dynamic components differ (1) among diabetic patients without autonomic neuropathy and with it and healthy control subjects, and (2) among the upper and lower extremities. Patients and Methods: BSBF at four recording sites with predominantly nutritive capillary circulation (right and left caput ulnae, right and left medial malleolus) was measured by laser Doppler flowmetry in 25 diabetic patients without cardiovascular autonomic neuropathy (D), 18 neuropathic diabetic patients (DAN) and 36 healthy controls (C). Wavelet transform was applied to the laser Doppler signal. Results: In absolute terms, mean flow, mean amplitude of the total spectrum and mean amplitudes at all frequency intervals were highest in C, followed by DAN and lowest in D. However, these differences were statistically significant only in the left arm. Within all three groups, mean flow and spectral amplitudes were significantly higher in the arms than in the legs, besides there was a significant difference between the two arms in D. Conclusion: We have confirmed the differences in BSBF among D, DAN and C, and demonstrated differences among the four recording sites which have not been previously described. The latter indicates an uneven progression of autonomic neuropathy and allows for speculation that the left arm is the latest to be affected.

Keywords:
Autonomic nervous system, Diabetic angiopathies, Diabetic neuropathies, Diagnostic techniques, Cardiovascular, Laser Doppler flowmetry, Laterality, Microcirculation, Nonlinear dynamics, Pulsatile flow
1.
Flynn MD, Tooke JE: Diabetic neuropathy and the microcirculation. Diabet Med 1995;12:298–301.
2.
Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553–1579.
3.
Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491–498.
4.
Bernardi L, Rossi M, Leuzzi S, et al: Reduction of 0.1 Hz microcirculatory fluctuations as evidence of sympathetic dysfunction in insulin-dependent diabetes. Cardiovasc Res 1997;34:185–191.
5.
Bornmyr S, Castenfors J, Svensson H, Wroblewski M, Sundkvist G, Wollmer P: Detection of autonomic sympathetic dysfunction in diabetic patients. A study using laser Doppler imaging. Diabetes Care 1999;22:593–597.
6.
Hilz MJ, Hecht MJ, Berghoff M, Singer W, Neundoerfer B: Abnormal vasoreaction to arousal stimuli – An early sign of diabetic sympathetic neuropathy demonstrated by laser Doppler flowmetry. J Clin Neurophysiol 2000;17:419–425.
7.
Katz A, Ekberg K, Johansson BL, Wahren J: Diminished skin blood flow in Type I diabetes: Evidence for non-endothelium-dependent dysfunction. Clin Sci (Lond) 2001;101:59–64.
8.
Veves A, Akbari CM, Primavera J, et al: Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457–463.
9.
McVeigh GE, Brennan GM, Johnston GD, et al: Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:771–776.
10.
Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510–2516.
11.
Calver A, Collier J, Vallance P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992;90:2548–2554.
12.
Hogikyan RV, Galecki AT, Pitt B, Halter JB, Greene DA, Supiano MA: Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity. J Clin Endocrinol Metab 1998;83:1946–1952.
13.
Makimattila S, Mantysaari M, Groop PH, et al: Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation 1997;95:618–625.
14.
De Meyer GR, Herman AG: Vascular endothelial dysfunction. Prog Cardiovasc Dis 1997;39:325–342.
15.
Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993;22:S1–S14.
16.
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–809.
17.
Bracic M, Stefanovska A: Wavelet-based analysis of human blood-flow dynamics. Bull Math Biol 198;60:919–935.
18.
Stefanovska A: Self-Organization of Biological Systems Influenced by Electrical Current. Thesis. Ljubljana, Faculty of Electrical Engineering, University of Ljubljana, Slovenia, 1992.
19.
Bollinger A, Yanar A, Hoffmann U, Franzeck UK: Is high-frequency fluxmotion due to respiration or to vasomotion activity? in Messmer K (ed): Progress in Applied Microcirculation. Basel, Karger, 1993, pp 52–58.
20.
Muck-Weymann ME, Albrecht HP, Hager D, Hiller D, Hornstein OP, Bauer RD: Respiratory-dependent laser-Doppler flux motion in different skin areas and its meaning to autonomic nervous control of the vessels of the skin. Microvasc Res 1996;52:69–78.
21.
Hoffmann U, Franzeck UK, Geiger M, Yanar A, Bollinger A: Variability of different patterns of skin oscillatory flux in healthy controls and patients with peripheral arterial occlusive disease. Int J Microcirc Clin Exp 1993;12:255–273.
22.
Kastrup J, Bulow J, Lassen NA: Vasomotion in human skin before and after local heating recorded with laser Doppler flowmetry. A method for induction of vasomotion. Int J Microcirc Clin Exp 1989;8:205–215.
23.
Meyer JU, Borgstrom P, Lindbom L, Intaglietta M : Vasomotion patterns in skeletal muscle arterioles during changes in arterial pressure. Microvasc Res 1988;35:193–203.
24.
Salerud EG, Tenland T, Nilsson GE, Oberg PA: Rhythmical variations in human skin blood flow. Int J Microcirc Clin Exp 1983;2:91–102.
25.
Soderstrom T, Stefanovska A, Veber M, Svensson H: Involvement of sympathetic nerve activity in skin blood flow oscillations in humans. Am J Physiol Heart Circ Physiol 2003;284:H1638–H1646.
26.
Kvernmo HD, Stefanovska A, Bracic M, Kirkeboen KA, Kvernebo K: Spectral analysis of the laser Doppler perfusion signal in human skin before and after exercise. Microvasc Res 1998;56:173–182.
27.
Stefanovska A, Bracic M, Kvernmo HD: Wavelet analysis of oscillations in the peripheral blood circulation measured by laser Doppler technique. IEEE Trans Biomed Eng 1999;46:1230–1239.
28.
Kvernmo HD, Stefanovska A, Kirkeboen KA, Kvernebo K: Oscillations in the human cutaneous blood perfusion signal modified by endothelium-dependent and endothelium-independent vasodilators. Microvasc Res 1999;57:298–309.
29.
Tooke JE, Brash PD: Microvascular aspects of diabetic foot disease. Diabet Med 1996;13:s26–s29.
30.
Wilson SB, Jennings PE, Belch JJ: Detection of microvascular impairment in type I diabetics by laser Doppler flowmetry. Clin Physiol 1992;12:195–208.
31.
Tur E, Yosipovitch G, Bar-On Y: Skin reactive hyperemia in diabetic patients. A study by laser Doppler flowmetry. Diabetes Care 1991;14:958–962.
32.
Stansberry KB, Peppard HR, Babyak LM, Popp G, McNitt PM, Vinik AI: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: A new model for the pathogenesis of microvascular dysfunction. Diabetes Care 1999;22:1549–1554.
33.
Stansberry KB, Hill MA, Shapiro SA, McNitt PM, Bhatt BA, Vinik AI: Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care 1997;20:1711–1716.
34.
Rendell M, Bamisedun O: Diabetic cutaneous microangiopathy. Am J Med 1992;93:611–618.
35.
Parkhouse N, Le Quesne PM: Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions N Engl J Med 1998;318:1306–1309.
36.
Nabuurs-Franssen MH, Houben AJ, Tooke JE, Schaper NC: The effect of polyneuropathy on foot microcirculation in Type II diabetes. Diabetologia 2002;45:1164–1171.
37.
McDaid EA, Monaghan B, Parker AI, Hayes JR, Allen JA: Peripheral autonomic impairment in patients newly diagnosed with type II diabetes. Diabetes Care 1994;17:1422–1427.
38.
Jorneskog G, Brismar K, Fagrell B: Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabet Med 1995;12:36–41.
39.
Caballero AE, Arora S, Saouaf R, et al: Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999;48:1856–1862.
40.
Nilsson GE, Tenland T, Oberg PA: Evaluation of a laser Doppler flowmeter for measurement of tissue blood flow. IEEE Trans Biomed Eng 1980;27:597–604.
41.
Leahy MJ, de Mul FF, Nilsson GE, Maniewski R: Principles and practice of the laser-Doppler perfusion technique. Technol Health Care 1999;7:143–162.
42.
Vinik AI, Erbas T, Park TS, Pierce KK, Stansberry KB: Methods for evaluation of peripheral neurovascular dysfunction. Diabetes Technol Ther 2001;3:29–50.
43.
Intaglietta M: Vasomotion and flow modulation in the microcirculation; in Intaglietta M (ed): Progress in Applied Microcirculation, vol 15. Basel, Karger, 1989, pp 1–9.
44.
Belcaro G, Nicolaides AN, Volteas N, Leon M: Skin flow the venoarteriolar response and capillary filtration in diabetics. A 3-year follow-up. Angiology 1992;43:490–495.
45.
Fromy B, Abraham P, Bouvet C, Bouhanick B, Fressinaud P, Saumet JL: Early decrease of skin blood flow in response to locally applied pressure in diabetic subjects. Diabetes 2002;51:1214–1217.
46.
Benbow SJ, Pryce DW, Noblett K, MacFarlane IA, Friedmann PS, Williams G: Flow motion in peripheral diabetic neuropathy. Clin Sci (Lond) 1995;88:191–196.
47.
Rendell M, Bergman T, O’Donnell G, Drobny E, Borgos J, Bonner RF: Microvascular blood flow, volume, and velocity measured by laser Doppler techniques in IDDM. Diabetes 1989;38:819–824.
48.
Jorneskog G, Fagrell B: Discrepancy in skin capillary circulation between fingers and toes in patients with type 1 diabetes. Int J Microcirc Clin Exp 1996;16:313–319.
49.
Fagrell B, Intaglietta M: Microcirculation: Its significance in clinical and molecular medicine. J Intern Med 1997;241:349–362.
50.
Arora S, Smakowski P, Frykberg RG, et al: Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care 1998;21:1339–1344.
51.
Mayrovitz HN, Larsen PB: Pulsatile blood flow asymmetry in paired human legs. Clin Physiol 1996;16:495–505.
52.
Cosson E, Paycha F, Tellier P, et al: Lower-limb vascularization in diabetic patients. Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy. Diabetes Care 2001;24:870–874.
53.
Tellier P: Whole-body thallium imaging in coronary artery disease. Angiology 1994;45:867–875.
54.
Bernardi L, Rossi M, Fratino P, Finardi G, Mevio E, Orlandi C: Relationship between phasic changes in human skin blood flow and autonomic tone. Microvasc Res 1989;37:16–27.
55.
Bernardi L, Radaelli A, Solda PL, et al: Autonomic control of skin microvessels: Assessment by power spectrum of photoplethysmographic waves. Clin Sci (Lond) 1996;90:345–355.
56.
Rossi M, Ricordi L, Mevio E, et al: Autonomic nervous system and microcirculation in diabetes. J Auton Nerv Syst 1990;3:S133–S135.
57.
Lefrandt JD, Bosma E, Oomen PH, et al: Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy. Diabetologia 2003;46:40–47.
58.
Meyer MF, Rose CJ, Hulsmann JO, Schatz H, Pfohl M: Impaired 0.1-Hz vasomotion assessed by laser Doppler anemometry as an early index of peripheral sympathetic neuropathy in diabetes. Microvasc Res 2003;65:88–95.
59.
Stansberry KB, Shapiro SA, Hill MA, McNitt PM, Meyer MD, Vinik AI: Impaired peripheral vasomotion in diabetes. Diabetes Care 1996;19:715–721.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.